특허실적
(Patents)
Use of purine ribonucleoside and its derivative as beta-lactamase inhibitor
Use of purine ribonucleoside and its derivative as beta-lactamase inhibitor
https://doi.org/10.8080/1020160090725
Use of β-nicotinamide adenine dinucleotide 2’-phosphate reduced (NADPH) and its derivatives as beta-lactamase inhibitors
Use of β-nicotinamide adenine dinucleotide 2’-phosphate reduced (NADPH) and its derivatives as beta-lactamase inhibitors
https://doi.org/10.8080/1020170093364
Licensing-out ₩ 500,000,000 (up-front payment + milestone payment)
Antibodies regulating functions of an endothelin receptor type A
Antibodies regulating functions of an endothelin receptor type A
https://doi.org/10.8080/1020190159941
Licensing-out ₩ 900,000,000 (up-front payment + milestone payment)
Antibody with enhanced binding to endothelin receptor type A
Antibody with enhanced binding to endothelin receptor type A
https://doi.org/10.8080/1020200060976
Licensing-out ₩ 2,000,000,000 (up-front payment + milestone payment)
Flavin mononucleotide binding protein variants derived from Arabidopsis thaliana with enhanced fluorescence intensity
Flavin mononucleotide binding protein variants derived from Arabidopsis thaliana with enhanced fluorescence intensity
https://doi.org/10.8080/1020190120443
Flavin mononucleotide binding protein variants derived from Pseudomonas putida with enhanced fluorescence intensity
Flavin mononucleotide binding protein variants derived from Pseudomonas putida with enhanced fluorescence intensity
@Copyright 2020. Jung-Hyun Na all rights reserved.